Stocks To Buy Now

Blog

The Stocks To Buy Now Blog

Our team has been covering the micro- and small-cap markets for more than a decade, exploring a wide variety of trends, technology and news in every industry. The Stocks to Buy Now blog seeks out undervalued companies, covers their news, breaks down the jargon, and delivers accurate and timely information to you on a daily basis.

If you’re looking for market insight, undervalued gems, and an assortment of investment options, read on.

Oakridge Global Energy Solutions, Inc. (OGES) Distinguishing Itself from the Market with the Quality of its Products and Services

Oakridge Global Energy Solutions, Inc. (OTCQB: OGES) is an integrated energy storage solutions company based in the U.S. The company uses state of the art technology in everything it does, from design to development and manufacturing. In 2016, OGES became the only U.S. manufacturer of lithium-ion batteries, positioning itself as a leader in the innovation […]

eXp World Holdings (EXPI) is floating on its Cloud Brokerage as New Home Sales rise to Eight-Year High

A press release (http://dtn.fm/eWZO4) issued yesterday by the Commerce Department reported that ‘sales of new single-family houses in April 2016 were at a seasonally adjusted annual rate of 619,000’. The estimates, prepared jointly by the U.S. Census Bureau and the Department of Housing and Urban Development, indicated that construction of new homes in the U.S. […]

Edison Issues Initiation on International Stem Cell Corp. (ISCO), Focus on Parkinson’s Potential

In a May 16, 2016, press release, Edison Investment Research announced initiation of coverage on International Stem Cell Corp. (OTCQB: ISCO). Edison describes itself as an international equity research firm with over 110 analysts and professionals, working with both large and small companies, as well as investors, wealth managers, private equity and corporate finance houses. […]

 

From Our Blog

Oncotelic Advances PLA from Published Liver Cancer Findings Toward 100 Billion Protein Vectors

October 29, 2026

Oncotelic Therapeutics Inc. (OTCQB: OTLC) is building its PDAOAI drug discovery engine around a compelling premise: a clue buried in a small corner of the literature can redirect an entire research program. Its Partitioned Literature Aggregation (“PLA”) algorithm is designed to uncover those clues. A liver-cancer study published in Biomedicines on October 23, 2026, now […]

Rotate your device 90° to view site.